SCHEMBL13289447

SCHEMBL13289447

Bc1cnn2c(NCc3cccc(NS(=O)(=O)c4cccc(OC)c4)c3)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 5/20 0.46
▸ CDK2 P24941 4/20 0.46
▸ KDR P35968 5/20 0.41
▸ RET P07949 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ ALPL P05186 1/20 0.40
▸ NAMPT P43490 1/20 0.39
▸ EGFR P00533 2/20 0.39
▸ FGFR1 P11362 2/20 0.39
▸ AURKA O14965 1/20 0.38
▸ AURKB Q96GD4 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ PTPN2 P17706 1/20 0.38
▸ PTPN1 P18031 1/20 0.38
▸ PTPN5 P54829 1/20 0.38
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13120774 0.91 CDK2 (0.57) GSK3BCDK2KDRRETGAA
SCHEMBL13288977 0.91 CDK2 (0.47) GSK3BCDK2GAANAMPTALDH1A1
SCHEMBL13288956 0.88 CDK2 (0.48) GSK3BCDK2KDRRETNAMPT
SCHEMBL13289444 0.88 CDK2 (0.49) GSK3BCDK2KDRRETNAMPT
SCHEMBL13288985 0.86 CDK2 (0.48) GSK3BCDK2KDRRETALDH1A1
SCHEMBL13289304 0.86 CDK2 (0.48) GSK3BCDK2KDRRETGAA
SCHEMBL13289239 0.86 GSK3B (0.51) GSK3BCDK2KDRRETMEN1
SCHEMBL13289093 0.85 CDK2 (0.48) GSK3BCDK2ALDH1A1MEN1KMT2A
SCHEMBL13289274 0.85 GSK3B (0.46) GSK3BCDK2GAAALPLALDH1A1
SCHEMBL13120722 0.84 CDK2 (0.61) GSK3BCDK2ALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2194058-A1 Pyrazolopyrimidines suitable for the treatment of cancer diseases SCHERING CORPORATION (US) 2010-06-09 — — EP disclosed
Send feedback